Canadian Minister of Industry, Science and Technology informed Institut Merieux that on the basis of data presented, the government questions the expediency of the firm's acquisition of Connaught BioSciences. Merieux said Oct. 13 that it has 30 days to supplement its application. Separately, the University of Toronto has agreed to consider dropping a lawsuit to block the acquisition while it considers a settlement agreement offered by Connaught. The university claims that non-Canadian ownership of the firm would violate an agreement between the university and the Canadian government. Connaught has accepted Merieux' $800 mil. cash offer of $37 a share.(ITEM 190)Picture, FDA -- Home Sweet Home
You may also be interested in...
The FDA has published fresh guidance taking a tougher stance on sponsor reasons for needing more time to respond to complete response letters.
Stada has named Yann Brun to become the group’s new head of global development, portfolio, regulatory and business development, replacing Robert Knerr. The move is the latest in a string of key appointments at Stada as the firm builds on a series of acquisitions and deals.
A letter from more than 60 leading public health and medical ethics experts has been sent to Pfizer's CEO Albert Bourla.